Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Auteurs

Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E

  • Date de publication

    Augustus 2025

  • Type

    Article

  • Tijdschrift

    Curr Opin Oncol

  • Naam van de onderzoeker

    DE CALUWE ALEX

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Radiothérapie

  • PMID

    40838320

  • DOI

    10.1097/CCO.0000000000001183